Key facts
- Vitazi.ai’s last known valuation is $8.9M (Feb 2026).
- It has raised $3.5M across 3 recorded rounds; the latest was Seed Round ($500K) in Dec 2025.
- Notable investors include Matter (Consulting Services (B2B)), Kickstart (US), Tramway Ventures.
- Vitazi.ai has filed 5 Form Ds with the SEC since 2022, most recently Feb 2026 ($500K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Vitazi.ai
Funding rounds
3 roundsAbout Vitazi.ai
Developer of diagnostics technology designed to detect disease, through artificial intelligence. The company offers hardware and software that are tied together and customized for user's needs to better evaluate their patients, meet required quality metrics, improve reimbursement, and reduce the long-term burden of preventable disease of vision loss and blindness, providing patients and healthcare professionals with real-time, valid detection of disease.
- Sector
- Healthcare
- HQ
- Santa Fe, NM, United States
- Founded
- 2021
- Employees
- 9
- Website
- vitazi.ai/
- Ownership
- Privately Held (backing)
Vitazi.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vitazi.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vitazi.ai in its N-PORT filings yet. We sweep new filings monthly.